Candel Therapeutics Grants Options on 107,600 Shares to Four New Employees
Bitget2026/11/02 21:12- Candel Therapeutics granted four new employees stock options to purchase 107,600 shares on Oct. 31, 2026.
- The options carry an exercise price of $8.33 per share under the 2025 Inducement Plan.
- Vesting covers 25% of the underlying shares on the first anniversary of each employee’s start date.
- The remaining 75% vests in 36 equal monthly installments thereafter. All vesting requires continued service through the applicable vesting date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Pendle Bridge integrates with BungeeExchange, supporting cross-chain transfers across 13 networks
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
Crypto prices
More
